Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel

Author： D'Souza Gerard GM   Cheng Shing-Ming   Boddapati Sarathi   Horobin Richard   Weissig Volkmar  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.16, Iss.7-8, 2008-08, pp. : 578-585

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Therapy: Targeting Mitochondria and other Sub-cellular Organelles

By  

Current Pharmaceutical Design, Vol. 20, Iss. 2, 2014-01 ,pp. : 201-222

Bentham Science Publishers

Access to resources Recommend Favorite

Rationally Designed Anti-mitotic Agents with Pro-Apoptotic Activity

By  

Current Pharmaceutical Design, Vol. 7, Iss. 16, 2001-11 ,pp. : 1627-1639

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Pro-Apoptotic Cancer Therapeutics

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 711-718

Bentham Science Publishers

Access to resources Recommend Favorite

Current Advances in the Synthesis and Antitumoral Activity of SIRT1-2 Inhibitors by Modulation of p53 and Pro-Apoptotic Proteins

By  

Current Medicinal Chemistry, Vol. 19, Iss. 34, 2012-12 ,pp. : 5871-5884

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Cellular Proapoptotic Molecules for Developing Anticancer Agents from Marine Sources

By  

Current Drug Targets, Vol. 11, Iss. 6, 2010-06 ,pp. : 708-715

Bentham Science Publishers

Access to resources Recommend Favorite